Vortioxetine hydrobromide Catalog No.:M10128-10 with pKis of 7

with pKis of 7

Selective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation

InChiKey: KWJRSHZSULRJHE-UHFFFAOYSA-N

and restored mean corpuscular volume and mean cell hemoglobin of red bloods cells

Vortioxetine hydrobromide Catalog No.:M10128-10 with pKis of 7Vortioxetine, also known as Lu AA21004, is an atypical antidepressant, and was approved in 2013 by the U. S. FDA for the treatment of major depressive disorder (MDD) in adults. Vortioxetine is a so called "serotonin modulator and stimulator." It has been shown to possess the following pharmacological actions: Serotonin transporter (SERT) blocker (i. e. serotonin reuptake inhibitor (SRI)) Ki (binding affinity) = 1. 6 nM, IC50 = 5. 4 nM; Norepinephrine